查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1997182

人工智慧手術機器人市場：按組件、機器人系統類型、自主等級、應用和最終用戶分類－2026-2032年全球市場預測

AI-based Surgical Robots Market by Component, Robotic System Type, Level of Autonomy, Application Areas, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，人工智慧手術機器人市場價值將達到 67.5 億美元，到 2026 年將成長至 70.9 億美元，到 2032 年將達到 103.4 億美元，複合年成長率為 6.27%。

主要市場統計數據
基準年 2025 67.5億美元
預計年份：2026年 70.9億美元
預測年份 2032 103.4億美元
複合年成長率 (%) 6.27%

本文簡要概述了人工智慧驅動的手術機器人如何透過整合臨床精準性、數據生態系統和創新採購模式來重新定義外科手術服務的提供方式。

人工智慧（AI）驅動的手術機器人的出現，將機械精度與演算法決策支援相結合，拓展了臨床應用的可能性，並重塑了手術的規劃、引導和執行方式。這些技術正將外科手術實踐從單純的手工操作轉變為一個整合的數位生態系統，在這個系統中，成像、感測和數據分析相互融合，從而提高術中精度和術後效果。醫院、專科診所和門診手術中心的相關人員正在評估實施這些技術所帶來的各種權衡，包括臨床效益、工作流程整合、人員培訓和實施複雜性。

自主性、人工智慧成像、身臨其境型模擬和不斷發展的法規等方面的進步如何結合起來，將手術機器人轉變為可互通的臨床平台。

手術機器人領域正經歷著一場變革性的轉型，這主要得益於機器學習、感測器小型化和人機介面設計的進步。這些因素的結合正在提升系統的自主性和臨床效用。如今，術中決策支援系統利用多模態成像和長期結果資料訓練的模型，從而能夠提供情境化的指導，而不僅僅是簡單地複製操作。這項進展正在加速從以工具為中心的自動化向以平台為中心的生態系統轉變，後者整合了軟體、硬體和服務。

2025 年美國關稅措施將如何影響外科機器人產業的供應鏈重組、零件採購轉變和韌性策略？

美國將於2025年實施的關稅將對用於手術機器人平台的高精度零件和子系統組件的全球供應鏈造成巨大壓力。依賴跨境採購控制電子設備、成像模組和專用致動器的製造商正面臨採購成本上升和前置作業時間波動加劇的困境，迫使他們進行策略調整，轉向供應商多元化和近岸外包。這些調整通常需要對零件供應商進行重新認證並更新監管申請，這需要額外的時間和合規投入。

詳細的細分洞察揭示了組件架構、自主層級、系統類型、臨床應用和最終用戶需求如何塑造策略和差異化。

對市場區隔的深入理解揭示了影響產品開發和市場進入策略的獨特技術和商業性趨勢。在考慮組件時，控制系統、成像系統、機械臂、感測器和致動器等硬體類別構成了平台性能的基礎，而安裝、培訓、維護和支援等服務則決定了生命週期成本和臨床運作。此外，由人工智慧和機器學習演算法、用於手術模擬的擴增實境(AR) 和虛擬實境 (VR) 技術以及資料分析和決策支援系統組成的軟體層，正日益成為提供臨床價值和持續收入的差異化因素。在評估機器人系統類型時，可以明顯看出以下差異：以演算法決策為優先的人工智慧驅動的自主機器人系統；依賴固定電源、資料鏈路並整合到現有手術室的有線機器人系統；以及為便攜性和受限環境提供新型部署模式的無線機器人系統。

美洲、歐洲、中東和非洲以及亞太地區的區域臨床重點、監管環境和製造生態系統如何決定戰略市場方法。

區域趨勢潛移默化地影響著產品優先順序、監管互動和商業化策略。在美洲，醫療保健系統強調大規模網路採購、與電子健康記錄的整合以及以結果為導向的採購，而創新叢集促進醫療設備製造商和手術中心之間的緊密合作，從而推動器械設計改進和真實世界數據（REW）的生成。這種環境有利於快速試點部署，但同時也需要強力的安全性和有效性證據，以確保在不同類型的醫院中廣泛應用。

競爭動態的形成，源自於成熟企業進入軟體生態系統、Start-Ups創新自主技術，以及推動整合臨床解決方案和差異化的夥伴關係。

手術機器人領域的競爭格局呈現出兩極化的特點：一方面是成熟的醫療設備製造商正將業務拓展至軟體主導服務領域；另一方面是敏捷的Start-Ups公司，它們專注於自主性、特定應用或新型人機互動介面。大型成熟企業憑藉豐富的部署經驗、穩固的醫院合作關係以及支援部署的臨床試驗網路，保持領先優勢。然而，新興企業正迅速迎頭趕上，它們利用機器學習、模組化硬體設計以及雲端原生軟體的突破性進展，這些軟體可以在部署後進行迭代更新，從而提升效能並增加功能。

市場領導可採取的策略重點是平衡模組化設計、監管合規規劃、培訓生態系統、軟體貨幣化和供應鏈彈性。

產業領導者應優先採取一系列策略行動，以管理風險並在快速發展的生態系統中創造臨床價值。首先，投資於模組化產品架構，將專有子系統與通用組件分離，以減輕關稅相關成本波動的影響，並實現分階段升級，而無需更換整個平台。這種設計方法支援區域製造柔軟性，並縮短國際客戶的服務回應時間。其次，將監管合規性和真實世界證據 (REW) 規劃整合到產品開發生命週期中，以簡化核准流程，並建立保險公司和醫療保健系統部署所需的可靠結果報告。儘早與監管機構和保險公司合作將減少上市後摩擦，並改善報銷談判。

採用穩健的混合調查方法，結合專家訪談、第二手資料整合、基準測試和情境分析，以檢驗策略見解和趨勢。

這些研究成果的研究途徑結合了對一手定性資料的結構化審查和透過二手資訊進行的嚴格檢驗，以確保分析的完整性。一手研究包括對外科醫生、採購負責人和醫療設備工程師的深度訪談，以獲取關於臨床效用、推廣障礙和採購考量的第一手觀點。除了這些訪談之外，還諮詢了監管和衛生經濟學專家，以明確營運環境中的合規性和報銷影響。

這是一份全面的指南，旨在透過實際應用、培訓和強大的商業化，將機器人和人工智慧創新轉化為可重複的臨床價值。

先進機器人技術、人工智慧和身臨其境型模擬的融合正開啟外科醫學的新篇章，其特點是精準度和可重複性顯著提升，並有望擴大高品質治療的覆蓋範圍。相關人員必須應對日益複雜的臨床證據要求、監管預期和經濟壓力之間的相互作用，同時抓住軟體主導的差異化和服務導向型商業模式所帶來的機會。成功的關鍵在於使產品設計與臨床醫生的工作流程相契合，展現可衡量的臨床和營運效益，並建立穩健的供應和支援體系。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：人工智慧手術機器人市場：按組件分類

  • 硬體
    • 控制系統
    • 影像系統
    • 機械臂
    • 感測器和致動器
  • 服務
    • 安裝和培訓
    • 維護和支援
  • 軟體
    • 人工智慧和機器學習演算法
    • 擴增實境（AR）和虛擬實境（VR）在外科手術模擬中的應用
    • 數據分析與決策支援系統

第9章：按機器人系統類型分類的人工智慧手術機器人市場

  • 人工智慧驅動的自主機器人系統
  • 有線機器人系統
  • 無線機器人系統

第10章：以自主程度分類的人工智慧手術機器人市場

  • 全自動手術機器人
  • 半自動自主手術機器人
  • 受監督的人工智慧輔助機器人

第11章：按應用分類的人工智慧手術機器人市場

  • 心胸外科
  • 一般外科
  • 婦科手術
  • 神經外科
  • 整形外科
  • 泌尿系統手術

第12章：人工智慧手術機器人市場：按最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第13章：人工智慧手術機器人市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：人工智慧手術機器人市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：人工智慧手術機器人市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國人工智慧手術機器人市場

第17章：中國人工智慧手術機器人市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Accuray Incorporated
  • Activ Surgical, Inc.
  • Asensus Surgical US, Inc.
  • CMR Surgical Limited
  • Globus Medical, Inc.
  • Intuitive Surgical, Inc.
  • Johnson & Johnson Services, Inc.
  • KUKA AG
  • Medtronic PLC
  • Monteris Medical Corporation
  • Moon Surgical
  • Neocis, Inc.
  • Noah Medical Corporation
  • Olympus Corporation
  • Robocath SAS
  • Shimadzu Corporation
  • Siemens AG
  • Smith & Nephew PLC
  • Stereotaxis, Inc.
  • Stryker Corporation
  • Synaptive Medical Inc.
  • THINK Surgical, Inc.
  • Titan Medical Inc.
  • Virtual Incision Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-035590447F03

The AI-based Surgical Robots Market was valued at USD 6.75 billion in 2025 and is projected to grow to USD 7.09 billion in 2026, with a CAGR of 6.27%, reaching USD 10.34 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.75 billion
Estimated Year [2026] USD 7.09 billion
Forecast Year [2032] USD 10.34 billion
CAGR (%) 6.27%

A succinct framing of how AI-driven surgical robotics are converging clinical precision, data ecosystems, and novel procurement models to redefine surgical care delivery

The emergence of artificial intelligence-driven surgical robots is reshaping how surgery is planned, guided, and executed, combining mechanical precision with algorithmic decision support to expand clinical possibilities. These technologies are shifting surgical practice from manual dexterity alone to an integrated digital ecosystem where imaging, sensing, and data analytics converge to improve intraoperative accuracy and postoperative outcomes. Stakeholders across hospitals, specialty clinics, and ambulatory surgical centers are evaluating adoption trade-offs that include clinical benefit, workflow integration, staff training, and procurement complexity.

Clinical teams are increasingly exposed to systems that augment surgeon capabilities through enhanced visualization, tremor filtration, and predictive assistance. As a result, adoption considerations extend beyond device performance to encompass software lifecycle management, cybersecurity posture, and interoperability with electronic health records and imaging archives. Simultaneously, vendors are adapting business models to deliver subscription-based software updates, training-as-a-service, and outcome-linked maintenance, which require new procurement constructs and contracting frameworks.

This introduction positions the technology as a multifaceted value proposition that intersects clinical efficacy, operational efficiency, and long-term digital strategy. It sets the stage for a deeper exploration of how technological maturation, regulatory pathways, and economic pressures are catalyzing the next wave of surgical innovation across care environments.

How advances in autonomy, AI-enhanced imaging, immersive simulation, and regulatory evolution are collectively transforming surgical robotics into interoperable clinical platforms

The landscape for surgical robotics is undergoing transformative shifts driven by advances in machine learning, sensor miniaturization, and human-machine interface design that collectively elevate system autonomy and clinical utility. Intraoperative decision support now benefits from models trained on multimodal imaging and longitudinal outcomes, enabling tools that provide context-aware guidance rather than simple motion replication. This progression fosters a move from tool-centric automation to platform-centric ecosystems that integrate software, hardware, and services.

Concurrently, augmented reality and virtual reality for surgical simulation are reducing the learning curve for complex procedures, permitting more rapid clinician onboarding and standardized competency assessments. These immersive technologies are not merely training adjuncts; they are becoming integral to preoperative planning, rehearsal, and intraoperative navigation. The result is a stronger synergy between preoperative analytics and intraoperative execution, improving case efficiency and reducing variability.

Regulatory frameworks and payer attitudes are also shifting to reflect evidence of comparative effectiveness and patient safety. Regulators are increasingly focused on algorithm transparency, real-world performance monitoring, and post-market surveillance, while payers and hospitals evaluate reimbursement pathways that reward outcomes and resource optimization. Taken together, these forces are accelerating ecosystem collaboration among device manufacturers, software developers, health systems, and academic centers, steering the industry toward interoperable, evidence-driven solutions that promise measurable impact on surgical quality and access.

Assessing how the 2025 United States tariff measures are driving supply chain reconfiguration, component sourcing shifts, and resilience strategies across surgical robotics

The introduction of tariffs in the United States in 2025 is exerting measurable pressure on global supply chains for high-precision components and subsystem assemblies used in surgical robotic platforms. Manufacturers that rely on cross-border sourcing of control electronics, imaging modules, and specialized actuators face elevated procurement costs and increased lead-time volatility, prompting strategic shifts in supplier diversification and near-shoring. These adjustments often require requalification of component suppliers and updates to regulatory submissions, introducing additional time and compliance investments.

Hospitals and clinics are feeling downstream effects as procurement cycles lengthen and total cost of ownership calculations become more complex. Capital-intensive acquisitions are subject to reassessment when component inflation alters service contract pricing and replacement part economics. In response, vendors are accelerating vertical integration where feasible, securing long-term supply agreements, and redesigning systems to reduce reliance on tariff-affected inputs. Concurrently, some companies are exploring modular product architectures that permit localized sourcing of non-critical elements while maintaining centralized manufacturing of proprietary subsystems.

Policy responses are also shaping investment and rollout strategies. Organizations with global footprints are reallocating production capacity to jurisdictions with favorable trade terms and stabilizing inventory through strategic stockpiles of critical components. For stakeholders planning multi-year procurement programs, the tariff environment raises the importance of contractual flexibility, indexed pricing clauses, and collaboration with suppliers to mitigate disruption. Overall, the 2025 tariff environment is accelerating resilience planning and driving a reassessment of supply chain and product design priorities across the surgical robotics ecosystem.

Deep segmentation insights revealing how component architecture, autonomy levels, system typologies, clinical applications, and end-user needs shape strategy and differentiation

A granular understanding of market segments reveals distinct technology and commercial dynamics that influence product development and go-to-market strategies. When considering components, hardware categories such as control systems, imaging systems, robotic arms, and sensors and actuators form the backbone of platform performance, while services including installation and training as well as maintenance and support determine lifecycle cost and clinical uptime; software layers comprising AI and machine learning algorithms, augmented and virtual reality for surgical simulation, and data analytics and decision support systems are increasingly the differentiators that deliver clinical value and recurring revenue. Evaluating robotic system types highlights divergence between AI-enabled autonomous robotic systems that prioritize algorithmic decision-making, tethered robotic systems that rely on fixed power or data links and established operating room integration, and untethered robotic systems that offer portability and novel deployment models for constrained environments.

Autonomy level further stratifies offerings into fully autonomous surgical robots designed for closed-loop execution of well-defined procedures, semi-autonomous systems that share control dynamically with the surgeon, and supervised AI-assisted robotics that augment human decision-making without relinquishing procedural control. Application areas create clinical contours for technology deployment, spanning cardiothoracic interventions where precision and vascular control are critical, general surgery with high procedure volume and varied anatomies, gynecological procedures that require minimally invasive dexterity, neurosurgery demanding submillimeter accuracy, orthopedic applications focused on structural alignment, and urology where constrained workspaces are common. End-user considerations are equally consequential: ambulatory surgical centers prioritize throughput and cost-efficiency, hospitals require comprehensive interoperability and service contracts, and specialty clinics demand targeted clinical workflows and reimbursement alignment. Synthesizing these segmentation lenses enables tailored product roadmaps and differentiated commercial strategies that address the unique clinical, operational, and regulatory needs of each segment.

How regional clinical priorities, regulatory landscapes, and manufacturing ecosystems across the Americas, Europe Middle East & Africa, and Asia-Pacific determine strategic market approaches

Regional dynamics shape product prioritization, regulatory engagement, and commercialization strategies in nuanced ways. In the Americas, health systems emphasize large-network procurement, integration with electronic health records, and outcome-driven purchasing, while innovation clusters foster close collaboration between medtech firms and surgical centers to iterate device design and real-world evidence generation. This environment supports rapid pilot deployments but also demands robust evidence on safety and efficiency to secure broader adoption across diverse hospital types.

In Europe, the Middle East & Africa, regulatory harmonization and variable reimbursement landscapes require manufacturers to adopt granular country-level strategies that align clinical value propositions with national procurement frameworks. Europe's established centers of surgical excellence often serve as early adopters for high-complexity systems, whereas markets in the Middle East and Africa may prioritize solutions that improve access and scalability. Manufacturers must therefore balance investment in regulatory approvals and localized training programs with adaptable commercial models.

Across Asia-Pacific, high-growth urban centers are investing in cutting-edge surgical technologies and parallel clinical research collaborations, while other markets prioritize cost-effective and scalable solutions. The region's manufacturing capabilities and component ecosystems also offer opportunities for localized production and shorter supply chains. Understanding these regional distinctions enables companies to tailor product configurations, service offerings, and partnership approaches to match payer expectations, clinical workflows, and infrastructure realities across markets.

Competitive dynamics shaped by incumbents expanding into software ecosystems, startups innovating autonomy, and partnerships driving integrated clinical solutions and differentiation

Competitive dynamics in the surgical robotics arena are defined by a mixture of established medical device firms expanding into software-driven services and agile startups focused on autonomy, niche applications, or novel human-machine interfaces. Leading incumbents retain advantages through expansive installed bases, established hospital relationships, and access to clinical trial networks that support adoption. However, challengers are accelerating by leveraging breakthroughs in machine learning, modular hardware design, and cloud-native software that can be updated iteratively to improve performance and add features post-deployment.

Partnerships between device manufacturers and software specialists are becoming essential to deliver integrated solutions that combine precise actuation with contextual clinical intelligence. In parallel, collaborations with academic centers and surgical societies are critical for building evidence frameworks and clinician trust. Intellectual property around control algorithms, haptic feedback, and safety interlocks remains a strategic asset, while regulatory clearances for algorithmic components are an increasing source of competitive differentiation. Mergers and acquisitions are selectively used to acquire talent, fill product gaps, or accelerate market entry into specialized clinical segments.

For procurement teams, the ability to evaluate vendors on clinical outcomes, total cost of ownership, cybersecurity, and training infrastructure is shifting negotiation dynamics. Companies that demonstrate strong post-market surveillance, upgrade pathways, and transparent performance metrics are more likely to secure long-term contracts and service agreements that underpin sustainable revenue streams.

Actionable strategic priorities for market leaders to balance modular design, regulatory planning, training ecosystems, software monetization, and supply chain resilience

Industry leaders should prioritize a set of strategic actions to capture clinical value while managing risk in a rapidly evolving ecosystem. First, invest in modular product architectures that decouple proprietary subsystems from commodity elements to reduce exposure to tariff-induced cost swings and enable incremental upgrades without full platform replacement. This design approach also supports regional manufacturing flexibility and accelerates time-to-service for international customers. Second, embed regulatory and real-world evidence planning into product development lifecycles to streamline approvals and to build robust outcomes dossiers that payers and health systems require for adoption. Early engagement with regulators and payers will reduce post-market friction and improve reimbursement discussions.

Third, develop comprehensive training and credentialing pathways using immersive simulation and competency-based assessments to shorten learning curves and increase clinical confidence. These programs should be integrated into commercial offerings and coupled with measurable performance metrics. Fourth, create software monetization strategies that balance device sales with recurring revenue from algorithm updates, analytics subscriptions, and outcome-based services. Fifth, strengthen supply chain resilience through supplier diversification, strategic inventories for critical components, and selective vertical integration where feasible. Finally, pursue targeted partnerships with clinical networks and technology firms to co-develop application-specific solutions that demonstrate clear value propositions and facilitate broader acceptance among surgeons and health system leaders.

A robust mixed-methods research methodology combining expert interviews, secondary evidence synthesis, benchmarking, and scenario analysis to validate strategic insights and trends

The research approach underlying these insights combined a structured review of primary qualitative inputs and rigorous secondary-source validation to ensure analytical integrity. Primary engagement included in-depth interviews with surgeons, procurement officers, and device engineers to capture first-hand perspectives on clinical utility, adoption barriers, and procurement considerations. These conversations were complemented by consultations with regulatory specialists and health economics experts to frame compliance and reimbursement implications within operational contexts.

Secondary research synthesized peer-reviewed literature, clinical trial registries, patent filings, and public regulatory databases to corroborate technical claims and trace innovation trajectories. Technology benchmarking assessed control architectures, imaging modalities, and autonomy frameworks to identify common design patterns and points of differentiation. Data triangulation methods reconciled inputs across sources and surfaced consensus findings versus areas of divergence that warrant further investigation. Scenario analysis was applied to examine the implications of policy shocks, supply chain disruptions, and accelerated software deployment on adoption pathways. Together, these methods support a balanced, evidence-informed narrative tailored to decision-makers evaluating strategy, procurement, or investment in surgical robotics.

Concluding synthesis on translating robotics and AI innovation into reproducible clinical value through pragmatic implementation, training, and resilient commercialization

The convergence of advanced robotics, artificial intelligence, and immersive simulation is ushering in a new chapter for surgical care, characterized by enhanced precision, reproducibility, and the potential to expand access to high-quality interventions. Stakeholders must navigate an increasingly complex matrix of clinical evidence requirements, regulatory expectations, and economic pressures while seizing opportunities presented by software-driven differentiation and service-oriented commercial models. Success will depend on the ability to align product design with clinician workflows, demonstrate measurable clinical and operational benefits, and construct resilient supply and support systems.

Looking ahead, the most effective organizations will be those that balance technological ambition with pragmatic implementation strategies: building modular platforms, investing in clinician-centric training, and establishing transparent performance monitoring. Strategic partnerships and flexible commercialization models will accelerate adoption and enable solutions to address diverse clinical settings. Ultimately, the pace and pattern of adoption will be determined by the industry's capacity to translate algorithmic promise into reproducible clinical value and reliable, cost-effective care delivery across health systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. AI-based Surgical Robots Market, by Component

  • 8.1. Hardware
    • 8.1.1. Control Systems
    • 8.1.2. Imaging Systems
    • 8.1.3. Robotic Arms
    • 8.1.4. Sensors & Actuators
  • 8.2. Services
    • 8.2.1. Installation & Training
    • 8.2.2. Maintenance & Support
  • 8.3. Software
    • 8.3.1. AI & Machine Learning Algorithms
    • 8.3.2. Augmented Reality (AR) & Virtual Reality (VR) for surgical simulation
    • 8.3.3. Data Analytics & Decision Support Systems

9. AI-based Surgical Robots Market, by Robotic System Type

  • 9.1. AI-Enabled Autonomous Robotic Systems
  • 9.2. Tethered Robotic Systems
  • 9.3. Untethered Robotic Systems

10. AI-based Surgical Robots Market, by Level of Autonomy

  • 10.1. Fully Autonomous Surgical Robots
  • 10.2. Semi-Autonomous Surgical Robots
  • 10.3. Supervised AI-Assisted Robotics

11. AI-based Surgical Robots Market, by Application Areas

  • 11.1. Cardiothoracic Surgery
  • 11.2. General Surgery
  • 11.3. Gynecological Surgery
  • 11.4. Neurosurgery
  • 11.5. Orthopedic Surgery
  • 11.6. Urology Surgery

12. AI-based Surgical Robots Market, by End-User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals
  • 12.3. Specialty Clinics

13. AI-based Surgical Robots Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. AI-based Surgical Robots Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. AI-based Surgical Robots Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States AI-based Surgical Robots Market

17. China AI-based Surgical Robots Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Accuray Incorporated
  • 18.6. Activ Surgical, Inc.
  • 18.7. Asensus Surgical US, Inc.
  • 18.8. CMR Surgical Limited
  • 18.9. Globus Medical, Inc.
  • 18.10. Intuitive Surgical, Inc.
  • 18.11. Johnson & Johnson Services, Inc.
  • 18.12. KUKA AG
  • 18.13. Medtronic PLC
  • 18.14. Monteris Medical Corporation
  • 18.15. Moon Surgical
  • 18.16. Neocis, Inc.
  • 18.17. Noah Medical Corporation
  • 18.18. Olympus Corporation
  • 18.19. Robocath SAS
  • 18.20. Shimadzu Corporation
  • 18.21. Siemens AG
  • 18.22. Smith & Nephew PLC
  • 18.23. Stereotaxis, Inc.
  • 18.24. Stryker Corporation
  • 18.25. Synaptive Medical Inc.
  • 18.26. THINK Surgical, Inc.
  • 18.27. Titan Medical Inc.
  • 18.28. Virtual Incision Corporation
  • 18.29. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL AI-BASED SURGICAL ROBOTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES AI-BASED SURGICAL ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA AI-BASED SURGICAL ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY CONTROL SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY CONTROL SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY CONTROL SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC ARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC ARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC ARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SENSORS & ACTUATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SENSORS & ACTUATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SENSORS & ACTUATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY INSTALLATION & TRAINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY INSTALLATION & TRAINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY INSTALLATION & TRAINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY AI & MACHINE LEARNING ALGORITHMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY AI & MACHINE LEARNING ALGORITHMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY AI & MACHINE LEARNING ALGORITHMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY AUGMENTED REALITY (AR) & VIRTUAL REALITY (VR) FOR SURGICAL SIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY AUGMENTED REALITY (AR) & VIRTUAL REALITY (VR) FOR SURGICAL SIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY AUGMENTED REALITY (AR) & VIRTUAL REALITY (VR) FOR SURGICAL SIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY DATA ANALYTICS & DECISION SUPPORT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY DATA ANALYTICS & DECISION SUPPORT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY DATA ANALYTICS & DECISION SUPPORT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY AI-ENABLED AUTONOMOUS ROBOTIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY AI-ENABLED AUTONOMOUS ROBOTIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY AI-ENABLED AUTONOMOUS ROBOTIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY TETHERED ROBOTIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY TETHERED ROBOTIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY TETHERED ROBOTIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY UNTETHERED ROBOTIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY UNTETHERED ROBOTIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY UNTETHERED ROBOTIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY FULLY AUTONOMOUS SURGICAL ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY FULLY AUTONOMOUS SURGICAL ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY FULLY AUTONOMOUS SURGICAL ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SEMI-AUTONOMOUS SURGICAL ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SEMI-AUTONOMOUS SURGICAL ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SEMI-AUTONOMOUS SURGICAL ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SUPERVISED AI-ASSISTED ROBOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SUPERVISED AI-ASSISTED ROBOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SUPERVISED AI-ASSISTED ROBOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY CARDIOTHORACIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY CARDIOTHORACIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY CARDIOTHORACIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY UROLOGY SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY UROLOGY SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY UROLOGY SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 174. GCC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GCC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 176. GCC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 177. GCC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 178. GCC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 179. GCC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. GCC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 181. GCC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 182. GCC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 201. G7 AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. G7 AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 203. G7 AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 204. G7 AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 205. G7 AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 206. G7 AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. G7 AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 208. G7 AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 209. G7 AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 210. NATO AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. NATO AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 212. NATO AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 213. NATO AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 214. NATO AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 215. NATO AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. NATO AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 217. NATO AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 218. NATO AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES AI-BASED SURGICAL ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA AI-BASED SURGICAL ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)